Cargando…
Upregulation of MYBL2 independently predicts a poorer prognosis in patients with clear cell renal cell carcinoma
MYB protooncogene-like 2 (MYBL2) is a transcription factor that is upregulated and significantly associated with various human cancer types. However, the potential role of MYBL2 in clear cell renal cell carcinoma (ccRCC) is yet to be elucidated. Therefore, the expression and biological functions of...
Autores principales: | Sun, Shan-Shan, Fu, Yang, Lin, Jian-Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068560/ https://www.ncbi.nlm.nih.gov/pubmed/32218829 http://dx.doi.org/10.3892/ol.2020.11408 |
Ejemplares similares
-
Overexpression of MYBL2 predicts poor prognosis and promotes oncogenesis in endometrial carcinoma
por: Le, Lulu, et al.
Publicado: (2021) -
INHBA upregulation correlates with poorer prognosis in patients with esophageal squamous cell carcinoma
por: Lyu, Shanshan, et al.
Publicado: (2018) -
Ceruloplasmin overexpression is associated with oncogenic pathways and poorer survival rates in clear‐cell renal cell carcinoma
por: Zhang, Yong, et al.
Publicado: (2021) -
Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis
por: Fu, Yang, et al.
Publicado: (2019) -
miRNAs in Prediction of Prognosis in Clear Cell Renal Cell Carcinoma
por: Ran, LongJiao, et al.
Publicado: (2017)